1. Home
  2. OMH vs GBIO Comparison

OMH vs GBIO Comparison

Compare OMH & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMH
  • GBIO
  • Stock Information
  • Founded
  • OMH 2015
  • GBIO 2016
  • Country
  • OMH Singapore
  • GBIO United States
  • Employees
  • OMH N/A
  • GBIO N/A
  • Industry
  • OMH Real Estate
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMH Finance
  • GBIO Health Care
  • Exchange
  • OMH Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • OMH 35.8M
  • GBIO 29.5M
  • IPO Year
  • OMH 2023
  • GBIO 2020
  • Fundamental
  • Price
  • OMH $1.13
  • GBIO $6.15
  • Analyst Decision
  • OMH Hold
  • GBIO Buy
  • Analyst Count
  • OMH 1
  • GBIO 4
  • Target Price
  • OMH N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • OMH 28.7K
  • GBIO 788.3K
  • Earning Date
  • OMH 09-24-2025
  • GBIO 11-05-2025
  • Dividend Yield
  • OMH N/A
  • GBIO N/A
  • EPS Growth
  • OMH N/A
  • GBIO N/A
  • EPS
  • OMH N/A
  • GBIO N/A
  • Revenue
  • OMH $7,976,578.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • OMH $28.40
  • GBIO N/A
  • Revenue Next Year
  • OMH $23.07
  • GBIO N/A
  • P/E Ratio
  • OMH N/A
  • GBIO N/A
  • Revenue Growth
  • OMH 117.53
  • GBIO 61.15
  • 52 Week Low
  • OMH $0.59
  • GBIO $3.00
  • 52 Week High
  • OMH $5.46
  • GBIO $29.10
  • Technical
  • Relative Strength Index (RSI)
  • OMH 44.43
  • GBIO 58.34
  • Support Level
  • OMH $1.05
  • GBIO $5.63
  • Resistance Level
  • OMH $1.14
  • GBIO $6.05
  • Average True Range (ATR)
  • OMH 0.06
  • GBIO 0.32
  • MACD
  • OMH 0.00
  • GBIO -0.09
  • Stochastic Oscillator
  • OMH 40.00
  • GBIO 56.66

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: